Paragonix Technologies names Leonard A. R. Golding as CMO

Monday, June 25, 2012 11:11 AM

Paragonix Technologies, a medical device company of Cambridge, Mass., has appointed Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC, as chief medical officer.

Golding will be responsible for all clinical development activities related to the Paragonix’s Sherpa Cardiac Transport System. He will also immediately assume the position of chairman for the Paragonix clinical advisory board.

Golding currently serves on staff in the department of biomedical engineering at Cleveland Clinic and has a secondary appointment in the department of thoracic and cardiovascular surgery at Cleveland Clinic's main campus. He is also the project director for the NIH-funded development of a unique total artificial heart blood pump. In addition, Golding is an international speaker and has authored over 210 peer-reviewed publications.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs